Olanzapine
ZYPREXA
Atypical Antipsychotic
NADAC/unit
$0.0797
No Shortage
Tier 1: 251.1%
PA Req: 158.4%
25 Manufacturers
132 ANDAs
Olanzapine treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand ZYPREXA: Generic saves up to 99% per unit
Market Intelligence
2024-12-25 Class II Recall: Macleods Pharmaceuticals Ltd
Generic Manufacturers
ALKEM LABORATORIES LTDAMERICAN REGENT INCANTHEA PHARMA PRIVATE LTDAPOTEX INCASPIRO PHARMA LTDAUROBINDO PHARMA LTDBARR LABORATORIES INCCADILA PHARMACEUTICALS LTDCHARTWELL MOLECULAR HOLDINGS LLCCHEPLAPHARM REGISTRATION GMBHDR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDHEC PHARM USA INCHISUN PHARMACEUTICAL (HANGZHOU) CO LTDJUBILANT GENERICS LTDMACLEODS PHARMACEUTICALS LTDOMNIVIUM PHARMACEUTICALS LLCORBION PHARMACEUTICALS PRIVATE LTDPHARMOBEDIENT CONSULTING LLCQILU PHARMACEUTICAL CO LTDSANDOZ INCSTRIDES PHARMA INTERNATIONAL AGSUNSHINE LAKE PHARMA CO LTDTORRENT PHARMACEUTICALS LTDUBI PHARMA INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.